ARTICLE | Politics & Policy
CEO Roundtable on Cancer names Bradway chairman
December 4, 2015 2:47 AM UTC
Not-for-profit group CEO Roundtable on Cancer appointed Robert Bradway chairman for a three-year term. Bradway is chairman and CEO of Amgen Inc. (NASDAQ:AMGN).
Bradway succeeds Christopher Viehbacher, managing partner of Gurnet Point Capital and former CEO of Sanofi (Euronext:SAN; NYSE:SNY) (see BioCentury, June 29). ...